UNITED THERAPEUTICS (UTHR) director exercises options and sells 1,300 shares under 10b5-1 plan

robot
Abstract generation in progress

Christopher Causey, a director at UNITED THERAPEUTICS Corp (UTHR), exercised stock options for 1,300 shares at $119.76 per share and simultaneously sold 1,300 shares at $604.64 per share. These transactions, executed on March 30, 2026, were pre-planned under a Rule 10b5-1 trading plan established on September 30, 2025. Following these trades, Causey directly holds 4,190 shares of Common Stock.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin